Cigir Biray Avci Selected Research

Paranasal Sinus Neoplasms

5/2020

PI3K/AKT/mTOR pathway and autophagy regulator genes in paranasal squamous cell carcinoma metastasis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cigir Biray Avci Research Topics

Disease

13	Neoplasms (Cancer) 06/2022 - 10/2014
8	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2022 - 10/2014
5	Glioblastoma (Glioblastoma Multiforme) 12/2020 - 09/2013
3	Leukemia 07/2022 - 01/2022
3	Glioma (Gliomas) 07/2016 - 09/2015
2	Breast Neoplasms (Breast Cancer) 07/2022 - 10/2020
2	Anaplastic Thyroid Carcinoma 05/2022 - 10/2020
1	Hematologic Diseases (Blood Diseases) 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 11/2021
1	Colonic Neoplasms (Colon Cancer) 11/2021
1	Neoplasm Metastasis (Metastasis) 10/2020
1	Thyroid Neoplasms (Thyroid Cancer) 10/2020
1	Paranasal Sinus Neoplasms 05/2020
1	COVID-19 01/2020
1	Infections 01/2020
1	Basal Cell Carcinoma (Rodent Ulcer) 03/2019
1	Margins of Excision 03/2019
1	Primary Myelofibrosis (Myelosclerosis) 01/2019
1	Hematologic Neoplasms (Hematological Malignancy) 12/2018
1	Liver Neoplasms (Liver Cancer) 05/2018
1	Hepatitis B 05/2018
1	Brain Neoplasms (Brain Tumor) 09/2016

Drug/Important Bio-Agent (IBA)

3	Dasatinib (BMS 354825)FDA Link 06/2022 - 01/2022
3	ponatinibIBA 01/2022 - 10/2014
3	Long Noncoding RNAIBA 01/2022 - 09/2016
3	BIBR 1532IBA 11/2021 - 12/2018
2	Tyrosine Kinase InhibitorsIBA 07/2022 - 01/2022
2	PolyphenolsIBA 05/2022 - 10/2014
2	TeaIBA 05/2022 - 10/2014
2	epigallocatechin gallate (epigallocatechin-3-gallate)IBA 05/2022 - 10/2014
2	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2020
2	Protein-Tyrosine Kinases (Tyrosine Kinase)IBA 01/2022 - 01/2019
2	EnzymesIBA 01/2022 - 12/2018
2	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2020 - 12/2018
2	ruxolitinibIBA 01/2020 - 01/2019
1	1-pentyl-3-(1-naphthoyl)indoleIBA 07/2022
1	Growth Factor ReceptorsIBA 07/2022
1	Monoclonal AntibodiesIBA 07/2022
1	CannabinoidsIBA 07/2022
1	Immunoconjugates (Immunoconjugate)IBA 07/2022
1	Angiogenesis InhibitorsIBA 07/2022
1	Therapeutic UsesIBA 07/2022
1	Cyclin-Dependent Kinase 4IBA 07/2022
1	Hormones (Hormone)IBA 07/2022
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 07/2022
1	Biological ProductsIBA 07/2022
1	dabrafenibIBA 05/2022
1	Okadaic AcidIBA 01/2022
1	Phosphoprotein Phosphatases (Phosphatases, Protein)IBA 01/2022
1	RNA (Ribonucleic Acid)IBA 01/2022
1	Protein Phosphatase 2 (Protein Phosphatase 2A)IBA 01/2022
1	Methanol (Carbinol)IBA 01/2022
1	ResveratrolIBA 11/2021
1	Temozolomide (Temodar)FDA LinkGeneric 12/2020
1	AZD3463IBA 12/2020
1	Eukaryotic Initiation Factor-4EIBA 10/2020
1	Pioglitazone (Actos)FDA Link 10/2020
1	Metformin (Glucophage)FDA LinkGeneric 10/2020
1	TOR Serine-Threonine KinasesIBA 10/2020
1	AMP-Activated Protein KinasesIBA 10/2020
1	ErbB Receptors (EGF Receptor)IBA 03/2019
1	1-phenyl-3,3-dimethyltriazene (PDT)IBA 01/2019
1	Contrast MediaIBA 01/2019
1	titanium dioxide (Titania)FDA Link 01/2019
1	ChromatinIBA 12/2018
1	DNA (Deoxyribonucleic Acid)IBA 05/2018
1	Small Interfering RNA (siRNA)IBA 05/2018
1	RE1-silencing transcription factorIBA 07/2016
1	Synapsins (Synapsin I)IBA 07/2016
1	Co-Repressor ProteinsIBA 07/2016
1	NitrogenIBA 05/2016
1	Diphosphonates (Bisphosphonates)IBA 05/2016
1	Zoledronic Acid (Zometa)FDA Link 05/2016
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 09/2015
1	bcr-abl Fusion ProteinsIBA 10/2014
1	Genetic Markers (Genetic Marker)IBA 09/2013

Therapy/Procedure

9	Therapeutics 07/2022 - 09/2015
3	Aftercare (After-Treatment) 06/2022 - 11/2021
1	Radiotherapy 01/2019
1	Photochemotherapy (Photodynamic Therapy) 01/2019